Literature DB >> 12452615

Squamous and/or glandular differentiation in urothelial carcinoma: prevalence and significance in transurethral resections of the bladder.

A Billis1, A A Schenka, C C Ramos, L T Carneiro, V Araújo.   

Abstract

BACKGROUND: It is controversial if urothelial carcinoma of the bladder with squamous and/or glandular differentiation is a more aggressive neoplasm than conventional urothelial carcinoma.
DESIGN: A total of 165 transurethral resections of the bladder were reviewed. A group with squamous and/or glandular differentiation was compared to a group without this finding. The chi-square test was used to assess the association of the groups with stage (TNM, 1997).
RESULTS: Of the total of 165 transurethral resections of the bladder, 153 (92.72%) were conventional urothelial carcinomas and 12 (7.27%) showed squamous and/or glandular differentiation. The distribution according to stage was 84 (54.9%), 35 (22.9%) and 34 (22.2%) for the group without differentiation and 0 (0%), 3 (25%) and 9 (75%) for the group with squamous and/or glandular differentiation, respectively for stages pTa, pT1 and pT2. Tumors with squamous and/or glandular differentiation showed a significant statistical correlation to higher stage at clinical presentation (p < 0.0001). There was no significant statistical relation according to age (p = 0.8433), sex (p = 0.5672) or race (p = 0.3137).
CONCLUSIONS: The results suggest that urothelial bladder carcinomas with squamous and/or glandular differentiation are more aggressive neoplasms. There was a significant statistical correlation between tumors with this differentiation and higher stage at clinical presentation.

Entities:  

Mesh:

Year:  2001        PMID: 12452615     DOI: 10.1023/a:1020597611645

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  7 in total

1.  Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.

Authors:  C J Logothetis; F H Dexeus; C Chong; A Sella; A G Ayala; J Y Ro; S Pilat
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

2.  Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder.

Authors:  J E Martin; B J Jenkins; R J Zuk; J P Blandy; S I Baithun
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

3.  Mixed differentiation of primary carcinoma of the urinary bladder.

Authors:  D A Grace; C C Winter
Journal:  Cancer       Date:  1968-06       Impact factor: 6.860

4.  Adenocarcinoma and transitional cell carcinoma occurring simultaneously in the urinary bladder (mixed tumor).

Authors:  J P Fegen; D J Albert; L Persky
Journal:  J Surg Oncol       Date:  1971       Impact factor: 3.454

5.  The impact of squamous metaplasia in transitional cell carcinoma of the bladder.

Authors:  A Akdaş; L Türkeri
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases.

Authors:  N Sakamoto; M Tsuneyoshi; M Enjoji
Journal:  Histopathology       Date:  1992-08       Impact factor: 5.087

7.  The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.

Authors:  H A Frazier; J E Robertson; R K Dodge; D F Paulson
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

  7 in total
  17 in total

1.  Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.

Authors:  Ling Cao; Xu Dong Zhou; Mary Ann Sens; Scott H Garrett; Yun Zheng; Jane R Dunlevy; Donald A Sens; Seema Somji
Journal:  J Appl Toxicol       Date:  2010-07       Impact factor: 3.446

2.  The effect of squamous and/or glandular differentiation on recurrence, progression and survival in urothelial carcinoma of bladder.

Authors:  Fikret Erdemir; Murat Tunc; Faruk Ozcan; Bekir S Parlaktas; Nihat Uluocak; Isin Kilicaslan; Ozgur Gokce
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

3.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

4.  Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.

Authors:  Aaron Dotson; Allison May; Facundo Davaro; Syed Johar Raza; Sameer Siddiqui; Zachary Hamilton
Journal:  Int J Clin Oncol       Date:  2019-02-01       Impact factor: 3.402

5.  Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.

Authors:  Jing Xie; Xue-Bin Zhang; Jin Wen; Yu-Shi Zhang; Han-Zhong Li
Journal:  Int Urol Nephrol       Date:  2016-01-21       Impact factor: 2.370

6.  Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma.

Authors:  Naohiro Makise; Teppei Morikawa; Taketo Kawai; Tohru Nakagawa; Haruki Kume; Yukio Homma; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

8.  Is radical cystectomy mandatory in every patient with variant histology of bladder cancer.

Authors:  Nandakishore Kamalakar Shapur; Ran Katz; Dov Pode; Amos Shapiro; Vladimir Yutkin; Galina Pizov; Liat Appelbaum; Kevin C Zorn; Mordechai Duvdevani; Ezekiel H Landau; Ofer N Gofrit
Journal:  Rare Tumors       Date:  2011-04-04

9.  Nonbilharzial squamous cell carcinoma and transitional cell carcinoma with squamous differentiation of the lower and upper urinary tract.

Authors:  Steffen Rausch; Rainer Hofmann; Rolf von Knobloch
Journal:  Urol Ann       Date:  2012-01

10.  Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.

Authors:  Peng Ge; Zi-Cheng Wang; Xi Yu; Jian Lin; Qun He
Journal:  BMC Urol       Date:  2015-05-30       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.